RxDoctor Payments Data

Aaron Mangold, MD

Dermatology · Scottsdale, AZNPI 1376832196

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $152,771 of the $170,684 with a category attached, or 89.5%. 19 manufacturers reported payments, led by Regeneron at 27.1% of the total. 2025 is the largest year on record at $64,756, more than ten times the $5,859 reported in 2019. Among dermatology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$170,684in general payments, 2019–2025

Across 127 payments — averaging $1343.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$46K
  • Incyte Corporation$22K
  • Boehringer Ingelheim International GmbH$20K
  • Kyowa Kirin, Inc.$15K
  • Janssen Global Services, LLC$14K
  • Biocryst Pharmaceuticals, Inc.$13K
  • plus $41K from 13 others
$4,748,669in research payments, 2019–2025

Across 673 payments — averaging $7055.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$1.1M
  • Regeneron$1M
  • Incyte Corporation$924K
  • E.r. Squibb & Sons, L.L.C.$687K
  • AbbVie$459K
  • Argenx US, Inc.$264K
  • plus $339K from 5 others

What the payments were for

  • Consulting fees$152,77190%
  • Speaking & faculty fees$5500%
  • Travel & lodging$14,5249%
  • Food & beverage$2,2601%
  • Education$5790%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$170,684 in reported general payments places this provider in the 95th percentile of 305 dermatology providers in Arizona.

See all dermatology providers in Arizona

Medicare billing

Part B allowed, 2024
$194,278
Medicare patients
485
Services billed
2,862

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5020$216,890
Dupixent SyringeDupilumab40$179,921
RinvoqUpadacitinib28$176,185
Taltz AutoinjectorIxekizumab12$82,659
Bexarotene13$16,638
Mycophenolate Mofetil64$5,775
Hydroxychloroquine Sulfate110$3,317
Gabapentin108$3,133
MethotrexateMethotrexate Sodium132$2,763
Triamcinolone Acetonide149$2,325
Clobetasol Propionate52$2,238
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc66$2,130
Mirtazapine40$1,952
Doxycycline Monohydrate43$1,109
ValacyclovirValacyclovir Hcl59$1,084

Paid to pharmacies, not to this prescriber.

Other dermatology in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →